P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy ; volume:2 ; number:2 ; day:12 ; month:3 ; year:2014 ; pages:1 ; date:3.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 2 (12.3.2014), 1, 3.2014
- Urheber
-
Sconocchia, G.
- Beteiligte Personen und Organisationen
-
Arriga, R.
Caratelli, S.
Coppola, A.
Spagnoli, GC
Lanzilli, G.
Capuani, B.
Ferrelli, F.
Lauro, D.
Ferrone, S.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-S2-P7
- URN
-
urn:nbn:de:1111-2016072657666
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sconocchia, G.
- Arriga, R.
- Caratelli, S.
- Coppola, A.
- Spagnoli, GC
- Lanzilli, G.
- Capuani, B.
- Ferrelli, F.
- Lauro, D.
- Ferrone, S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
NK cell regulation
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Tumor-priming converts NK cells to memory-like NK cells
Challenges of NK cell-based immunotherapy in the new era
Development of NK cell-based cancer immunotherapies through receptor engineering
NK cell-based cancer immunotherapy: from basic biology to clinical development
Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report
NK cells in the liver
NK Cells in HIV Disease
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
NK cell regulation
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Tumor-priming converts NK cells to memory-like NK cells
Challenges of NK cell-based immunotherapy in the new era
Development of NK cell-based cancer immunotherapies through receptor engineering
NK cell-based cancer immunotherapy: from basic biology to clinical development
Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report
NK cells in the liver
NK Cells in HIV Disease
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
NK cell regulation
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Tumor-priming converts NK cells to memory-like NK cells
Challenges of NK cell-based immunotherapy in the new era
Development of NK cell-based cancer immunotherapies through receptor engineering
NK cell-based cancer immunotherapy: from basic biology to clinical development
Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report
NK cells in the liver